Рет қаралды 2,887
The U.S. has approved the world’s first medicine to treat sickle-cell disease. Executives from the companies that developed the gene-edited treatment-Crispr Therapeutics and Vertex Pharmaceuticals-discuss the breakthrough's potential and risks.
#Biotech #Healthcare #WSJ